Founded in 2005, RadSite promotes quality-based practices for imaging systems across the United States and its territories. RadSite is recognized by the Centers for Medicare & Medicaid Services as an official accreditation organization under the Medicare Improvements for Patients and Providers Act of 2008. RadSite is also recognized by more than 350 payers and has accredited more than 2,000 imaging systems. The agency’s programs help assess, track, and report imaging trends to improve imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of safety issues and to promote best practices. The organization is governed by an independent advisory board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more, contact us at 443-440-6007 or info@radsitequality.com | RadSite is a nationally recognized accreditation organization providing high-quality, standards-based programs for diagnostic imaging facilities. We offer MRI Accreditation, CT Accreditation, Nuclear Medicine & PET Accreditation, Medical CBCT Accreditation, Dental CBCT Accreditation, Remote Scanning Accreditation and Ultrasound Accreditation. Our mission is to promote excellence in imaging through rigorous evaluation, quality assurance, and education. RadSite is governed by an independent advisory board and committee system, open to a wide range of volunteers to ensure transparency and accountability.
Radiology Partners
Radiology Partners is a leading physician-owned and physician-led radiology practice in the U.S., serving more than 3500 hospitals and other healthcare facilities across the nation. As a physician-led practice, our mission is to Transform Radiology™ by innovating across clinical value, service and economics, while elevating the role of radiology and radiologists in healthcare. Using a proven healthcare services model, Radiology Partners provides consistent, high quality care to patients, while delivering enhanced value to the hospitals, clinics, imaging centers, and referring physicians we serve
Radiology Imaging Associates
Radiology Imaging Associates is a trusted leader in advanced imaging, interventional radiology, teleradiology, and vascular services across Central Florida and throughout the East Coast. We partner with hospitals and radiology groups to deliver cutting-edge technology, fast report turnaround, subspecialty expertise, and long-standing clinical relationships.
Radia Inc. P.S.
100% Radiologist owned and governed private practice — onsite and teleradiology services.
Rad AI
Rad AI is the leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company’s flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company’s pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of U.S. radiologists. Rad AI Continuity, the most comprehensive solution of its kind, provides AI-driven patient follow-up. Rad AI is the fastest-growing radiologist-led AI company and has been recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software of 2023, Best New Radiology Vendor of 2021). An Accenture report in December 2023 highlighted Rad AI as having the highest influence score and brand buzz of any private company in radiology, solidifying its position as a leader in the field.
Qure.Ai Technologies Inc.
Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Our solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. We empower healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life. | About Qure.ai Qure.ai is a global health tech company that innovates AI-enabled healthcare solutions to drive early clinical diagnosis and boost seamless patient care coordination. Qure’s solutions power the efficient identification and management of TB, Lung Cancer and Neurocritical findings to support clinicians and propel developments in the pharmaceutical and medical device industries. The company empowers healthcare workers or health systems by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life. Qure.ai has deployments in over 100 countries, with regional offices in New York, London, Dubai and Mumbai. It is a TIME100 Most Influential Company 2025.
QMENTA
QMENTA provides AI-powered imaging infrastructure designed for radiology and clinical research. Our cloud-native platform centralizes image data, automates quality control, and supports advanced review workflows across multi-site studies. From data ingestion to central read and adjudication, QMENTA helps imaging teams ensure compliance, maintain data integrity, and accelerate study timelines.
PurpleAI
PurpleAI is a fast-growing medical AI pioneer transforming stroke care through intelligent automation—enhancing workflow efficiency and diagnostic accuracy to drive better patient outcomes. Building on the proven success of its diagnostic support AI solutions, PurpleAI is now expanding into multi-modal, predictive analytics. Its upcoming flagship SaMD, StrokeShieldAI, is designed to anticipate and monitor high-risk complications following initial stroke treatment. By equipping clinicians with real-time foresight, StrokeShieldAI enables earlier intervention, mitigates adverse outcomes, and sets a new standard for stroke care. | Founded as an independent company in October 2024 (after operating within SK Group since 2019), PurpleAI is a fast-growing medical AI innovator transforming stroke care through intelligent automation and predictive insight—enhancing workflow efficiency, diagnostic accuracy, and patient outcomes. PurpleAI is expanding its Hyper Insight™ portfolio across multiple imaging modalities and advancing into multi-modal, data-driven predictive analytics. Its upcoming flagship, StrokeShieldAI, is built to anticipate and monitor high-risk complications after initial stroke treatment—providing clinicians with real-time foresight for earlier intervention and better outcomes.